FGF-2 expression and its action in human leukemia and lymphoma cell lines
暂无分享,去创建一个
H Laurell | A. Hampl | P. Dvořák | H. Laurell | P Dvorak | P. Krejcí | A Hampl | P Krejci | J Faitova | J. Faitová | P. Dvořák
[1] H. Joensuu,et al. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma. , 1999, Blood.
[2] F. Amalric,et al. Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells. , 1995, Leukemia.
[3] B. Ross,et al. AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. , 1997, Cancer research.
[4] M. Shehata,et al. Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia. , 1999, Blood.
[5] H Laurell,et al. FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. , 2000, Molecular endocrinology.
[6] D. Rifkin,et al. Both normal and tumor cells produce basic fibroblast growth factor , 1986, Journal of cellular physiology.
[7] I. Delrieu. The high molecular weight isoforms of basic fibroblast growth factor (FGF‐2): an insight into an intracrine mechanism , 2000, FEBS letters.
[8] E. Estey,et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. , 2000, Blood.